This paper examines the financing, pricing, and utilization of pharmaceuticals in China the pharmaceutical system as it has evolved, and some changes that would improve it in the context of the national health reform process. The present paper builds upon earlier critical reviews and other papers published in the series china health policy notes. The paper is divided into four parts. The first section provides an overview of the Chinese pharmaceutical...
See More
DETAILS
-
2010/06/01
-
Working Paper (Numbered Series)
-
58410
-
2
-
2011/03/17
-
Disclosed
-
Main report
-
essential medicines
Citation
Hu,Shanlian.
Financing, pricing, and utilization of pharmaceuticals in China : the road to reform policy (Vol. 2 of 2) : Main report (Chinese). China health policy notes ; no. 1 Washington, DC: World Bank. http://documents.worldbank.org/curated/en/590351468018625366